Women’s health

Call to improve transparent communication in direct-to-consumer test marketing – Emma Grundtvig Gram et al.

2024-08-06T11:23:30+10:00HPV, Imaging, Low-value care, Overdiagnosis, Overtesting, Overuse, Publications, Screening, Tests, Too much|

All tests ‘(…) do harm; some do good as well, and, of these, some do more good than harm at reasonable cost.’ - Muir Gray and Angela Raffle. Medical tests are widely and increasingly marketed directly to consumers via traditional and social media. Such tests may [...]

Women’s interest, knowledge, and attitudes relating to anti-Mullerian hormone testing: a randomized controlled trial – T Copp et al.

2024-08-06T10:31:59+10:00Overtesting, Overuse, Publications, Tests, Women's health|

The anti-Mullerian hormone (AMH) can be measured by a blood test and gives an indication of the number of oocytes in the ovaries, but not of oocyte quality . Whilst the test is helpful in assisted reproduction as it roughly indicates the potential number of [...]

Cranberry Juice, Cranberry Tablets, or Liquid Therapies for Urinary Tract Infection: A Systematic Review and Network Meta-analysis – Christian Moro et al.

2024-08-02T11:41:43+10:00Antibiotics, Deprescribing, Publications, Treatment, Women's health|

With over 50% of women suffering from at least one episode of urinary tract infection (UTI) each year and an increasing prevalence of antimicrobial resistance, efforts need to be made to clearly identify the evidence supporting potential non-drug interventions. This study aims to compare the [...]

Digital breast tomosynthesis for breast cancer diagnosis in women with dense breasts and additional breast cancer risk factors: A systematic review – Smriti Raichand et al.

2024-07-30T15:47:29+10:00Breast cancer, Breast density, Cancer, Imaging, Publications, Screening, Women's health|

Digital breast tomosynthesis (DBT) may improve sensitivity in population screening. However, evidence is currently limited on the performance of DBT in patients at a higher risk of breast cancer. This systematic review compares the clinical effectiveness and cost-effectiveness of DBT, digital mammography (DM), and ultrasound, [...]

Factors associated with private or public breast cancer screening attendance in Queensland, Australia: A retrospective cross-sectional study – Tong Li et al.

2024-07-30T12:16:47+10:00Breast cancer, Cancer, Publications, Screening, Women's health|

This study aimed to estimate participation in private breast screening in Queensland, Australia, where public-funded screening is implemented, and to identify factors associated with the screening setting, using an online survey (999 female respondents aged 40-74). Screening-specific and socio-demographic factors were collected. Multivariable logistic regression [...]

Mammography Screening Preferences Among Screening-Eligible Women in Their 40s : A National U.S. Survey – Laura D Scherer et al.

2024-07-30T12:06:55+10:00Breast cancer, Cancer, Decision aids, Publications, Screening, Shared decision making, Women's health|

The U.S. Preventive Services Task Force (USPSTF) recently changed its recommendation for mammography screening from informed decision making to biennial screening for women aged 40 to 49 years. Although many women welcome this change, some may prefer not to be screened at age 40 years. [...]

Breast cancer screening from age 40 in the US – Katy JL Bell et al.

2024-07-30T11:45:58+10:00Breast cancer, Cancer, Health policy, Overdiagnosis, Publications, Risk, Screening, Women's health|

The US Preventive Services Task Force has updated its recommendation for the age when all women should start mammography screening, lowering it from 50 to 40. This change immediately affects more than 20 million American women and other people assigned female at birth who are [...]

The Conversation – Breast cancer screening in Australia may change. Here’s what we know so far

2024-07-29T14:08:30+10:00Breast cancer, News, Screening, Women's health|

The way women are screened for breast cancer in Australia may change. There’s international debate on the age women should be invited for screening. But an even larger change being considered worldwide is whether to screen women at high and low risk of breast cancer differently. But what such a [...]

The Guardian – Widely advertised hormone test unreliable as fertility prediction tool for women, researchers say

2024-07-29T14:04:31+10:00Fertility, News, Women's health|

Experts warn women are making ‘significant life changes’ based on the anti-Müllerian hormone test, which they say is not reliable for many of its advertised uses. Accredited fertility clinics are among companies misleading women about a blood test used to indicate fertility, resulting in women [...]

Go to Top